sorafenib has been researched along with EBV Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Deng, L; Fan, Z; Huang, F; Huang, X; Li, X; Liang, X; Liu, H; Liu, Q; Luo, X; Shi, P; Sun, J; Tu, S; Wang, Y; Xu, N; Xu, X; Xu, Y; Xuan, L | 1 |
1 trial(s) available for sorafenib and EBV Infections
| Article | Year |
|---|---|
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial.
Topics: Cytomegalovirus Infections; Epstein-Barr Virus Infections; fms-Like Tyrosine Kinase 3; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpesvirus 4, Human; Humans; Leukemia, Myeloid, Acute; Retrospective Studies; Sorafenib | 2022 |